Attention deficit disorder in adults and nicotine dependence: Psychobiological factors in resistance to recovery?

Journal of Psychoactive Drugs

Volumn 28, Issue 3, 1996, Pages 229-240

  Coger, Roger W ^a   Moe, Kathryn L ^b   Serafetinides, E A ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Attention Deficit Disorder; Nicotine dependence; Self medication; Substance abuse; Treatment

Indexed keywords

COCAINE; DEXAMPHETAMINE; METHYLPHENIDATE; NICOTINE;

ATTENTION; ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; DEPENDENT PERSONALITY DISORDER; DISEASE ASSOCIATION; DRUG DEPENDENCE; HUMAN; ILLNESS BEHAVIOR; MOOD; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGICAL ASPECT; REVIEW; SELF MEDICATION;

EID: 0029819155     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1996.10472484     Document Type: Article

References (84)

1. Ahadpour, M.; Horton, A.M. & Vaeth, J.M. 1993. Attention deficit disorder and drug abuse. International Journal of Neuroscience72:89-93.
2. Alburges, M.K.; Narang, N. & Wamsley, J.K. 1993. Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse14:314-23.
3. Alessandri, S.M. & Schramm, K. 1991. Effects of dextroamphetamine on the cognitive and social play of a preschooler with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry30:768-72.
4. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders.4th ed. Washington, D.C.: American Psychiatric Association.
5. Anderson, K.; Fuxe, K.; Eneroth, P.; Mascagni, F. & Agnati, L.F. 1985. Effects of acute intermittent exposure to cigarette smoke on catecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and corticosterone. Acta Psychiatrica Scandinavica124:277-85.
6. Aoyama, T.; Kotaki, H.; Sawada, V. & Iga, T. 1994. Stereospccific distribution of methylphenidate enantiomers in rat brain: Specific binding to dopamine reuptake sites. Pharmacological Research11:407-11.
7. Armitage, A.K.; Hall, G.H. & Morrison, C.F. 1968. Pharmacological basis for the tobacco smoking habit. Nature217:331-34.
8. Balfour, D.J.K. 1991. The influence of stress on psychopharmacological responses to nicotine. British Journal of Addiction86:489-93.
9. Biederman, J.; Faraone, S.V.; Keenan, K.; Benjamin, J.; Ixhman, B.K.; Moore, C.; Sprich-Buckminster, S.; Ugalia, K.; Jellinek, S.; Steingard, R.; Spencer, T.; Norman, D.; Kolodny, R.; Krauss, L.; Perrin, J.; Keller, M.B. & Tsuang, M.T. 1992. Further evidence for family-genetic risk factors in Attention Deficit Hyperactive Disorder. Archives of General Psychiatry49:728-38.
10. Biederman, J.; Faraone, S.V.; Mick, E.; Spencer, T.; Wilens, T.; Kiely, K.; Guite, J.; Abion, J.S.; Reed, E. & Warburton, R. 1995. High risk for Attention Deficit Hyperactive Disorder among children of parents with childhood onset of the disorder: A pilot study. American Journal of Psychiatry52:431-35.
11. Biederman, J.; Faraone, S.V.; Spencer, T.; Wilens, T.; Norman, D.; Ipey, K.A.; Mick, E.; Lehman, B.K. & Doyle, A. 1993. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with Attention Deficit Hyperactive Disorder. American Journal of Psychiatry150:1792-798.
12. Biederman, J.; Wilens, T.; Mick, E.; Milberger, S.; Spencer, T.J. & Faraone, S.V. 1995. Psychoactive substance use disorders in adults with Attention Deficit Hyperactivity Disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry152:1652-658.
13. Biel, J.H. & Bopp, B.A.1979. Amphetamines: Structure-activity relationships. In: L. Iverson, S. Iverson & S. Synder (Eds.)Handbook of Psychopharmacology. Volume 2.New York: Plenum.
14. Bradley, C. 1937. The behavior of children receiving Benzedrine. American Journal of Psychiatry94:577-85.
15. Brown, B.B. 1967. Relationship between evoked response changes and behavior following small doses of nicotine. Annals of the New York Academy of Sciences142:190-200.
16. Caine, S.B. & Koob, G.F. 1993. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science260:1814-816.
17. Castaneda, R.; Lifschutz, H.; Galanter, M. & Franco, H. 1994. Empirical assessment of the self-medication hypothesis among dually diagnosed inpatients. Comprehensive Psychiatry35:180-84.
18. Clifford, J.O. & Williston, J.S. 1992. Three dimensional vector analysis of the spatial components and voltage magnitudes of the P300 response during different attentional states and stimulus modalities. International Journal of Psychophysiology12:1-10.
19. Corrigall, W.A. 1991. Understanding brain mechanisms in nicotine reinforcement. British Journal of Addiction86:507-10.
20. Corrigall, W.A. & Coen, K.M. 1994. Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus. Pharmacology and Biochemistry of Behavior48:817-20.
21. Delfs, J.M.; Schreiber, L. & Kelley, A.E. 1990. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. Journal of Neuroscience10:303-10.
22. Domino, E.F. 1986. Nicotine: A unique psychoaclive drug-Arousal with skeletal muscle relaxation. Psychopharmacology Bulletin22:87074.
23. Edwards, J.A.; Wesnes, K. & Warburton, D.M. 1985. Evidence of more rapid stimulus following cigarette smoking. Addictive Behaviors10:113-26.
24. Faraone, S.V.; Biederman, J.; Chen, W.J.; Kritcher, B.; Keenan, K.; Moore, C.; Sprich, S. & Tsuang, M. 1992. Segregation analysis of Attention Deficit Hyperactive Disorder: Evidence for single gene transmission. Psychiatry Genetics2:257-75.
25. Faraone, S.V.; Biederman, J.; Keenan, K. & Tsuang, M.T. 1991. A family genetic study of girls with DSM-III Attention Deficit Disorder. American Journal of Psychiatry148:112-17.
26. Faraone, S.V.; Biederman, J.; Lehman, B.K.; Keenan, K.; Norman, D.; Seidman, L.J.; Kolodney, R.; Kraus, I.; Perrin, J. & Chen, W.J. 1993. Evidence for the independent familial transmission of Attention Deficit Hyperactive Disorder and learning disabilities: Results from a family genetic study. American Journal of Psychiatry1506:891-95.
27. Faraone, S.V.; Biederman, J. & Milberger, S. 1994. An exploratory study of ADHD among second-degree relatives of ADHD children. Biological Psychiatry35:398-402.
28. Gilbert, D.G. 1989. Emotion, anxiety and smoking. In: T. Ney & A. Gale (Eds.)Smoking and Human Behavior.New York: John Wiley & Sons.
29. Gilbert, D.G. 1979. Paradoxical tranquilizing and emotion-reducing effects of nicotine. Psychological Bulletin86:643-61.
30. Ginzel, K.H. 1967. Introduction to the effects of nicotine on the central nervous system. Annals of the New York Academy of Sciences142:101-20.
31. Gittelman, R.; Mannuzza, S.; Shenker, R. & Bonagura, N. 1985. Hyperactive boys almost grown up. Archives of General Psychiatry42:937-47.
32. Golding, J.F. 1988. Effects of cigarette smoking on resting EEG, visual evoked potentials and photic driving. Pharmacology, Biochemistry and Behavior29:23-32.
33. Goodwin, R.E. & Corgiat, M.D. 1992. Cognitive rehabilitation of Adult Attention Deficit Disorder: A case study. Journal of Cognitive Rehabilitation10:28-35.
34. Grenhoff, J.; Aston-Jones, G. & Svensson, T.H. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiologica Scandinavica128:351-58.
35. Hart, C. & Kasir, C. 1996. Nicotine effects on dopamine clearance in rat nucleus accumbens. Journal of Neurochemistry66:216-21.
36. Henningfield, J.E. & Janisky, D.R. 1983. Human pharmacology of nicotine. Psychopharmacology Bulletin19:412-15.
37. Hinshaw, S.P.; Buhrmester, D. & Heller, T. 1989. Anger control in response to verbal provocation: Effects of stimulant medication for boys with ADHD. Journal of Abnormal Child Psychology17:393-407.
38. Hoff, E.C. & Hockmann, C.H. 1967. Neurophysiological aspects of the action of nicotine. Annals of the New York Academy of Sciences142:121-25.
39. Hughes, J.R. 1988. Clonidine, depression and smoking cessation. Journal of the American Medical Association259:2901-902.
40. Jarvik, M.E. 1991. Beneficial effects of nicotine. British Journal of Addiction86:571-75.
41. Jarvik, M.E. & Pomerleau, O.F. 1986. Nicotine as a psychoactive drug: Anxiety and pain reduction, arousal, and appetite reduction. Psychopharmacology Bulletin22:863-64.
42. Kitchens, K.; Nezami, E. & Gjika, H.B. 1989. The effects of smoking on the mood, cardiovascular and adrenergic reactivity of heavy and light smokers in a non-stressful environment. Biological Psychiatry29:273-89.
43. Knott, V.J. 1988. Dynamic EEG changes during cigarette smoking. Neuropsychobiology19:54-60.
44. Kubo, T.; Amano, H.; Kurahashi, K. & Misu, Y. 1989. Nicotine-induced regional changes in brain noradrenalin and dopamine turnover in rats. Journal of Psychobiodynamics12:107-12.
45. Laufer, M.W. & Denhoff, E. 1957. The hyperkinetic behavior syndrome in children. Journal of Pediatrics50:463-73.
46. Lee, E.H. 1985. Effects of nicotine on exploratory behavior in rats: Correlation with regional brain monoamine levels. Behavioral Brain Research17:59-66.
47. Levin, E.D.; Rose, J.E. & Abood, L. 1995. Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacology, Biochemistry and Behavior51:369-73.
48. Lie, N. 1992. Follow-ups of children with Attention Deficit Hyperactivity Disorder (ADHD): Review of the literature. Acta Psychiatrica Scandinavica368 (suppl.): 1-40.
49. Lucchesi, B.R.; Schuster, C.R. & Emley, C.S. 1967. The role of nicotine as a determinant of cigarette smoking in man with observations of certain cardiovascular effects associated with the tobacco alkaloid. Clinical Pharmacology and Therapeutics8:789-96.
50. Mangan, G.L. & Golding, J.F. 1984. Smoking: Motivation and models. In: T. Ney & A. Gale (Eds.)Smoking and Human Behaviour. Chichester, England: Wiley.
51. Marks, M.J.; Burch, J.B. & Collins, A.C. 1983. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics226:817-25.
52. Matochik, J.A.; Liebenauer, L.; King, A.C.; Szymanski, H.V.; Cohen, R.M. & Zametkin, A.J. 1994. Cerebral glucose metabolism in adults with Attention Deficit Hyperactivity Disorder after chronic stimulant treatment. American Journal of Psychiatry151:658-64.
53. Milich, R.; Carlson, C.L.; Pelham, W.E. Jr. & Licht, G.G. 1991. Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology19:519-36.
54. Myerson, A. 1936. Effect of Benzedrine sulfate on mood and fatigue in normal and neurotic persons. Archives of Neurology and Psychiatry36:816.
55. Nesbitt, P.D. 1973. Smoking, physiological arousal, and emotional response. Journal of Personality and Social Psychology25:137-44.
56. Nisell, M.; Nomikos, G.G. & Svensson, T.H. 1995. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacology and Toxicology76:157-62.
57. Nisell, M.; Nomikos, G.G. & Svensson, T.H. 1994. Infusion of nicotine in the ventral trigeminal area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacology and Toxicology75:348-52.
58. Norton, R.; Howard, R.C. & Brown, K. 1991. Dose-dependent effects of smoking on P300 and mood. Medical Science Research19:355-56.
59. O’Neil, S. & Parrott, A.C. 1992. Stress and arousal in sedative and stimulant smokers. Psychopharmacology107:442-48.
60. Parrott, A.C. 1993. Cigarette smoking: Effects upon self-rated stress and arousal over the day. Addictive Behaviors18:389-95.
61. Pickworth, W.B.; Heming, R.I. & Henningfield, J.E. 1989. Spontaneous EEG changes during tobacco abstinence and nicotine substitution in human volunteers. Journal of Pharmacology and Experimental Therapy251:976-82.
62. Pincus, J. & Glaser, G. 1966. The syndrome of “minimal brain damage” in childhood. New England Journal of Medicine275:27-35.
63. Pomcrleau, O.F. 1986. Nicotine as a psychoactive drug: Anxiety and pain reduction, arousal and appetite regulation. Psychopharmacology Bulletin22:863-64.
64. Raitcri, M.; Bertollini, A.; Angelini, F. & Levy, G. 1975. β-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synapsomes. European Journal of Pharmacology34:95.
65. Raskin, L.A.; Shaywitz, S.E.; Shaywitz, B.A.; Anderson, G.M. & Cohen, D.J. 1984. Neurochemical correlates of Attention Deficit Disorder. Pediatric Clinics of North America31:387-96.
66. Ratey, J.J.; Greenberg, M.S.; Bemporad, J.R. & Lindem, K.J. 1992. Unrecognized Attention-Deficit Hyperactive Disorder in adults presenting for outpatient psychotherapy. Journal of Child and Adolescent Psychopharmacology2:267-75.
67. Ritz, M.C.; Lamb, R.J.; Goldberg, S.R. & Kuhar, M.J. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science237:1219-223.
68. Romano, C.; Goldstein, A. & Jewell, N.P. 1981. Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology74:310-15.
69. Rowell, P.P.; Carr, L.A. & Garner, A.C. 1987. Stimulation of [3H]dopamine release by nicotine in rat nucleus acumbens. Journal of Neurochemistry49:1449-454.
70. Russell, M.A.H. & Jarvis, M.J. 1985. Theoretical background and clinical use of nicotine chewing gum. In: J. Gabowski & S. Hall (Eds.)Pharmacological Adjuncts in Smoking Cessation. NIDA Research Monograph 53. Rockville, Maryland: National Institute on Drug Abuse.
71. Schubinar, II.; Tzelepis, A.; Isaacson, J.H.; Warbasse, L.H., III; Zacharek, M. & Musial, J. 1995. The dual diagnosis of Attention-Deficit/ Hyperactivity Disorder and substance abuse: Case reports and literature review. Journal of Clinical Psychiatry56:46-50.
72. Shekim, W.O.; Asamow, R.F.; Hess, E. & Zaucha, K. 1990. A clinical demographic profile of a sample of adults with Attention Deficit Hyperactive Disorder. Comprehensive Psychiatry56:19-65.
73. Tannock, R.; Ickowicz, A. & Schachar, R. 1995. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry34:886-96.
74. Tsuang, D.; Cowley, D.; Ries, R. & Dünner, D.L. & Roy-Byme, P.P. 1995. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic. Journal of Clinical Psychiatry56:549-55.
75. Verbaten, M.N.; Overtoom, C.C.; Koelega, U.S.; Swaab-Bameveld, H.; van der Gaag, R.J.; Buitclaar, J. & van Engeland, H. 1994. Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test. Journal of Abnormal Child Psychology22:561-78.
76. Wameke, L. 1990. Psychostimulants in psychiatry. Canadian Journal of Psychiatry35:3-10.
77. Weiss, R.D. & Mirin, S.M. 1986. Subtypes of cocaine abusers. Psychiatric Clinics of North America9:491-501.
78. Wender, PH.; Reimherr, F.W. & Wood, D R. 1981. Attention Deficit Disorder (“minimal brain dysfunction”) in adults. Archives of General Psychiatry38:449-56.
79. Wender, P.H.; Reimherr, F.W.; Wood, D.R. & Ward, M. 1985. A controlled study of methylphenidate in the treatment of Attention Deficit Disorder, residual type, in adults. American Journal of Psychiatry142:547-52.
80. Wesnes, K. & Warburton, D M. 1983. Smoking, nicotine and human performance. Pharmacology and Therapeutics21:189-208.
81. White, R.W. 1959. Motivation reconsidered: 'Hie concept of competence. Psychological Review66:297-333.
82. Wolpe, J. 1958. Psychotherapy by Reciprocal Inhibition. Stanford, California: Stanford University Press.
83. Wood, D R.; Reimherr, F.W. & Wender, P.H. & Johnson, G.E. 1976. Diagnosis and treatment of minimal brain dysfunction in adults: A preliminary report. Archives of General Psychiatry33:1453-460.
84. Zainetkin, A.V.; Nordahl, T.E.; Gross, M.; King, A.C.; Semple, W.E.; Rumsey, J.; Hamburger, S. & Cohen, R.M. 1990. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine323:1361-366.